Immune thrombocytopenia in the elderly: Clinical course in 525 patients from a single center in China

Annals of Hematology

Volumn 92, Issue 1, 2013, Pages 79-87

  Zhou, Hu ^a,b   Fu, Rongfeng ^a   Wang, Hongmei ^a   Zhou, Fangfang ^a   Li, Huiyuan ^a   Zhou, Zeping ^a   Zhang, Lei ^a   Yang, Renchi ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Bleeding; Elderly patients; Immune thrombocytopenia (ITP); Treatment options

Indexed keywords

AMINO POLYPEPTIDE; ASCORBIC ACID; DANAZOL; HERBACEOUS AGENT; IMMUNOGLOBULIN G; INTERFERON; POLYPEPTIDE; PREDNISONE; RECOMBINANT THROMBOPOIETIN; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CHINA; CLINICAL FEATURE; COMORBIDITY; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEMATURIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MENORRHAGIA; MUCOSAL BLEEDING; PRIORITY JOURNAL; RELAPSE; REMISSION; RESPIRATORY TRACT HEMORRHAGE; RETROSPECTIVE STUDY; RISK FACTOR; SKIN BLEEDING; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHINA; COMORBIDITY; DANAZOL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872351632     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1567-2     Document Type: Article

References (28)

1. Nugent D, McMillan R, Nichol JL, Slichter SJ (2009) Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 146(6):585-596
2. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88(1):3-40
3. Bennett D, Hodgson ME, Shukla A, Logie JW (2011) Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom. Adv Ther 28(12):1096-1104
4. Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94(3):909-913
5. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97(9):2549-2554
6. Vianelli N, Valdre L, Fiacchini M, de Vivo A, Gugliotta L, Catani L, Lemoli RM, Poli M, Tura S (2001) Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 86(5):504-509
7. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T (1991) High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 77(1):31-33
8. Linares M, Cervero A, Colomina P, Pastor E, Lopez A, Perez A, Perella M, Carbonell F (1995) Chronic idiopathic thrombocytopenic purpura in the elderly. Acta Haematol 93(2-4):80-82
9. Michel M, Rauzy OB, Thoraval FR, Languille L, Khellaf M, Bierling P, Godeau B (2011) Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Am J Hematol 86(12):980-984
10. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168-186
11. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386-2393
12. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122(6):966-974
13. Segal JB, Powe NR (2006) Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Hemost 4(11):2377-2383
14. Feudjo-Tepie MA, Le Roux G, Beach KJ, Bennett D, Robinson NJ (2009) Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol 2009:963506
15. McMillan R, Durette C (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 104(4):956-960
16. Rodeghiero F, Besalduch J, Michel M, Provan D, Grotzinger K, Thompson G (2010) Treatment practices in adults with chronic immune thrombocytopenia - a European perspective. Eur J Haematol 84(2):160-168
17. Pang W, Li Z, Sun Z, Zheng L, Zhang X, Xu C, Liu S, Li J, Hu D, Sun Y (2010) Prevalence of hypertension and associated factors among older rural adults: results from Liaoning Province, China. Med Princ Pract 19(1):22-27
18. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31(1):177-188
19. O'Marra SK, Shaw SP, Delaforcade AM (2011) Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: a pilot study. J Vet Emerg Crit Care (San Antonio). doi: 10.1111/j.1476-4431.2011. 00658.x
20. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N (2002) Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol 81(8):436-440
21. George JN, el-Harake MA, Raskob GE (1994) Chronic idiopathic thrombocytopenic purpura. New Engl J Med 331(18):1207-1211
22. Karpatkin S (1997) Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 349(9064):1531-1536
23. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S (2008) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 99(1):4-13
24. Bizzoni L, Mazzucconi MG, Gentile M, Santoro C, Bernasconi S, Chiarotti F, Foa R, Mandelli F (2006) Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol 76(3):210-216
25. Imbach P, Kuhne T, Muller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR (2006) Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 46(3):351-356
26. Jubelirer SJ, Harpold R (2002) The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review. Clin Appl Thromb Hemost 8(1):73-76
27. JiJi RM, Firozvi T, Spurling CL (1973) Chronic idiopathic thrombocytopenic purpura. Treatment with steroids and splenectomy. Arch Intern Med 132(3):380-383
28. Watson-Williams EJ, Macpherson AI, Davidson S (1958) The treatment of idiopathic thrombocytopenic purpura; a review of ninety-three cases. Lancet 2(7040):221-226